Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesAliskiren: a novel renoprotective agent or simply an alternative to ACE inhibitors
Kidney International, 04/20/09
Wiggins KJ et al. - There are several theoretical reasons to suggest that aliskiren may have renoprotective actions superior to those of ACEis and ARBs. In this paper the available evidence regarding renoprotective effects of aliskiren is reviewed, with an emphasis on comparison with ACEis and ARBs.
Related Articles
Aliskiren Monotherapy Does Not Cause Paradoxical Blood Pressure Rises. Meta-Analysis of Data From 8 Clinical Trials
Hypertension, 11/17/09
Relevance Score: 89%
Recent changes in the landscape of combination RAS blockade
Expert Review of Cardiovascular Therapy, 11/18/09
Relevance Score: 80%
Today in Nephropathies...keeping you current
Receive free subspecialty "5-minute updates" via email
Foxp3 Staining in BK Virus Allograft Nephropathy and Comparison With Acute Cellular Rejection
Transplantation Proceedings, 12/18/09
Establishing the Molecular Pathways Involved in Chronic Allograft Nephropathy for Testing New Noninvasive Diagnostic Markers
Transplantation, 12/18/09
Prevalence and predictors of recurrent IgA nephropathy following renal transplantation
Irish Journal of Medical Science, 12/18/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Statin Therapy Ameliorates Renal Allograft Function
Transplantation Proceedings, 12/18/09
Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma
Journal of Clinical Oncology, 12/18/09
Effects of Cyclosporine-Tacrolimus Switching in Posttransplantation Hyperlipidemia on High-Density Lipoprotein 2/3, Lipoprotein A1/B, and Other Lipid Parameters
Transplantation Proceedings, 12/18/09
Article Search
Sponsor